Table 4.
Antitumor activity in evaluable patients (n = 16)
| Best response | No. patients | Tumor types | Reduction | 
|---|---|---|---|
| Partial response | 4 | Breast | Complete response in liver; stable disease in bone | 
| Stomach | ↓32% in lymph nodes | ||
| Gastroesophageal | |||
| Ocular melanoma | |||
| Minor response | 3 | Mesothelioma | ↓23% in lymph nodes | 
| Prostate | ↓30% in PSA | ||
| SCC H + N | ↓26% in lymph node | ||
| Stable disease | 7 | Prostate | |
| Unknown 1° | |||
| Melanoma | |||
| Esophagus | |||
| Pancreas |